Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., March 13, 2017 -- ReWalk Robotics Ltd. (Nasdaq:RWLK) today announced that Larry Jasinski, Chief Executive Officer, will present at the Oppenheimer 27th Annual Healthcare Conference as follows:
| Date: | Wednesday, March 22, 2017 |
| Time: | 3:55 p.m. Eastern Daylight Time |
| Location: | The Westin Grand Central, New York, NY |
The presentation will be webcast live at the aforementioned time, and archived for 90 days thereafter, via the Company’s website at: www.rewalk.com, under the Investors Section, or via the following link at: https://www.veracast.com/webcasts/opco/healthcare2017/08231104468.cfm.
About ReWalk Robotics Ltd.
ReWalk Robotics is an innovative medical device company that is designing, developing and commercializing exoskeletons allowing wheelchair-bound individuals to stand and walk once again. Our mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit http://www.rewalk.com.
ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel.
Contact: Lisa Wilson In-Site Communications, Inc. Investor Relations T: (212) 452-2793 E: [email protected]
